(Q64951611)

English

Biologic Activity of Spores and Dried Powder from Ganoderma lucidum for the Inhibition of Highly Invasive Human Breast and Prostate Cancer Cells

scientific article published on August 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Biologic Activity of Spores and Dried Powder from Ganoderma lucidum for the Inhibition of Highly Invasive Human Breast and Prostate Cancer Cells (English)

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Ganoderma lucidum

object named as

Ganoderma lucidum

1 reference

based on heuristic

inferred from title

author name string

Daniel Sliva

1

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Miroslav Sedlak

2

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Veronika Slivova

3

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Tatiana Valachovicova

4

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Frank P. Lloyd

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499024

11 March 2024

Nancy W. Y. Ho

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499024

11 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499024

11 March 2024

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/107555303322284776

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Journal of Alternative and Complementary Medicine

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

9

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

4

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

491-497

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer

2

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients

3

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.

4

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer

5

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

6

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

7

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and ERbeta: differential transcription activity between ferutinine-liganded ER(alpha) and ERbeta

9

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

10

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum

12

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

AP-1 blockade inhibits the growth of normal and malignant breast cells

13

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer

14

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells

15

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum

16

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer

17

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

The biochemistry of cancer dissemination

18

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells

19

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator

20

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer

21

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Agricultural and Biological Chemistry

22

49

2641

author name string

Sone Y

publication date

1985

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Herbal composition PC-SPES for management of prostate cancer: identification of active principles.

23

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines

24

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

25

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

PC-SPES--a lesson for future dietary supplement research

27

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes

28

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum

29

1 reference

10.1089/107555303322284776

https://api.crossref.org/works/10.1089/107555303322284776

11 March 2024

Identifiers

10.1089/107555303322284776

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/14499024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64951611&oldid=2099631723"